Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome
Neurogastroenterology & Motility · 2025-12 · 37 (12)
DOI: 10.1111/nmo.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 14.06.2025. Verfasst von María Cuende-Estévez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chronic Diseases and Metabolism (CHROMETA), Center for Intestinal Neuroimmune Interactions, Translational Research Center for Gastroint…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Rhinitis, Allergic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: KU Leuven, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Background
Patients with irritable bowel syndrome (IBS) have an increased risk of developing both airway and allergic diseases. However, the relationship between allergic rhinitis (AR), one of the most common chronic upper airway inflammatory diseases, and IBS remains poorly understood. The aim of this study is to provide a better understanding of airway complications in patients with IBS and to evaluate the presence of potential airborne and dietary antigen cross‐reactivity in concomitant IBS and AR.
Methods
A total of 287 participants, 54 healthy volunteers without gastrointestinal complaints and 232 patients with I fulfilling Rome IV criteria, were invited to complete self‐administered questionnaires assessing the severity of upper airway symptoms and the prevalence of allergic rhinitis.
Results
Overall, patients with IBS had a threefold higher risk of questionnaire‐based allergic rhinitis than control subjects (95% CI, 1.49–6.12). Furthermore, patients with IBS + AR showed reduced sleep quality, mood, and personal satisfaction associated with their upper airway complaints, compared to IBS patients without AR. Forty‐seven (18/38) percent of IBS + AR patients reported IBS symptoms in response to ingestion of food items with molecular mimicry of the aeroallergen to which the patient is sensitized.
Conclusion
Our study shows that patients with IBS have an increased frequency of concomitant allergic rhinitis, which contributes to a further reduction in quality of life. We also provide evidence of potential cross‐reactive reactions between aeroallergens and dietary antigens in patients with concomitant IBS and AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chronic Diseases and Metabolism (CHROMETA), Center for Intestinal Neuroimmune Interactions, Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
- Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
- Department of Neurosciences, Experimental Otorhinolaryngology, KU Leuven, Leuven, Belgium.
ORCID-Profile: Hind Hussein, Javier Aguilera-Lizarraga
Förderung
- KU Leuven
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Cuende-Estévez, M., Hussein, H., Pia, F., Backaert, W., Van Gerven, L., Aguilera-Lizarraga, J., & Boeckxstaens, G. E. (2025). Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70108
Vancouver
Cuende-Estévez M, Hussein H, Pia F, Backaert W, Van Gerven L, Aguilera-Lizarraga J, et al. Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70108
BibTeX
@article{CuendeEstvez2025,
author = {Cuende-Estévez, María and Hussein, Hind and Pia, Fedrica and Backaert, Wout and Van Gerven, Laura and Aguilera-Lizarraga, Javier and Boeckxstaens, Guy E},
title = {Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome},
journal = {Neurogastroenterology & Motility},
year = {2025},
volume = {37},
number = {12},
doi = {10.1111/nmo.70108}
}
EUVIMED